Loop Capital analyst David Williams maintains Plexus (NASDAQ:PLXS) with a Buy and raises the price target from $100 to $105.
JP Morgan Downgrades Novo Nordisk to Neutral
JP Morgan analyst Richard Vosser downgrades Novo Nordisk (NYSE:NVO) from Overweight to Neutral.